.Pharmacolibrary.Drugs.ATC.A.A02BC01_1 .Pharmacolibrary.Drugs.ATC.A.A02BC01_1| name: | Omeprazole_1 | |
| ATC code: | A02BC01_1 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 40 | mg |
| volume of distribution: | 0.35 | L |
| clearance: | 500 | ml/min |
| other parameters in model implementation | ||
Omeprazole is a proton pump inhibitor that blocks gastric acid secretion and is used for acid-related gastrointestinal disorders.
Pharmacokinetics in healthy subjects after single 40 mg intravenous bolus administration.
Solana, MJ, et al., & Carrillo, A (2014). Population pharmacokinetics of omeprazole in critically ill pediatric patients. Therapeutic drug monitoring 36(4) 519–527. DOI:10.1097/FTD.0000000000000033 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24365987
Piqué, JM, et al., & Hasselgren, G (2002). Pharmacokinetics of omeprazole given by continuous intravenous infusion to patients with varying degrees of hepatic dysfunction. Clinical pharmacokinetics 41(12) 999–1004. DOI:10.2165/00003088-200241120-00004 PUBMED:https://pubmed.ncbi.nlm.nih.gov/12222996
McCann, S, et al., & Gonzalez, D (2023). Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease. Clinical pharmacokinetics 62(7) 997–1009. DOI:10.1007/s40262-023-01254-2 PUBMED:https://pubmed.ncbi.nlm.nih.gov/37179512